• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about Novo Nordisk A/S

    Recent news which mentions Novo Nordisk A/S

    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
    Tags Companies Breaking news US: News
    From CNBC.com News
    Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
    Tags Business Roche Holding AG Business News
    From CNBC.com News
    Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
    Tags Business News Viking Therapeutics Inc Breaking News: Business
    From CNBC.com News
    Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
    Tags Pharmaceuticals Biotech and Pharmaceuticals Biotechnology
    From CNBC.com News
    Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
    Tags Health & Science Novartis AG Biotech and Pharmaceuticals
    From CNBC.com News
    Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
    Tags Health & Science Pharmaceuticals Biotech and Pharmaceuticals
    From CNBC.com News
    Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
    Tags Biotech and Pharmaceuticals Markets Pharmaceuticals
    From CNBC.com News
    Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
    Tags Merck & Co Inc UnitedHealth Group Inc Healthy Returns
    From CNBC.com News
    Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
    Tags Healthy Returns Health & Science Biotech and Pharmaceuticals
    From CNBC.com News
    Pfizer moves forward with once-daily version of weight loss pill after setbacks
    Tags Pfizer Inc Pharmaceuticals Biotechnology
    From CNBC.com News
    Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
    Tags Eli Lilly and Co Stock Picks Investment Strategy
    From CNBC.com News
    FTC to sue drug middlemen over prices of medications including insulin
    Tags Business US: News Social issues
    From CNBC.com News
    CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
    Tickers LAWS
    Tags Elections Paramount Global Economic outlook
    From CNBC.com News
    CNBC Daily Open: French far-right advance blocked
    Tags Bitcoin Cryptocurrency Market Outlook
    From CNBC.com News
    This ETF is trying to satisfy appetites for weight loss stocks
    Tags Prescription drugs U/S/ Markets Finance
    From CNBC.com News
    Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
    Tags Pharmaceuticals Science Health & Science
    From CNBC.com News
    Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
    Tags Novo Nordisk A/S Health care industry Oracle Corp
    From CNBC.com News
    Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
    Tags Healthy Returns Viking Therapeutics Inc Zealand Pharma A/S
    From CNBC.com News
    5 things to know before the stock market opens
    Tags Walt Disney Co Paramount Global Business
    From CNBC.com News
    Novo Nordisk's Wegovy weight loss drug approved in China
    Tags Eli Lilly and Co Biotech and Pharmaceuticals Europe: Top News And Analysis
    From CNBC.com News
    Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
    Tags Biotechnology Novo Nordisk A/S Health care industry
    From CNBC.com News
    Weight loss drug contender Zealand Pharma jumps 23% on trial results
    Tags Novo Nordisk A/S Eli Lilly and Co Europe Markets
    From CNBC.com News
    Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
    Tags Health care industry Novo Nordisk A/S Eli Lilly and Co
    From CNBC.com News
    How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
    Tags CNBC Changemakers Business News Pharmaceuticals
    From CNBC.com News
    European stocks set for muted open after European Central Bank cut
    Tags Europe Markets Novo Nordisk A/S World Economy
    From CNBC.com News
    Why half of all workers may struggle to get weight-loss drug health insurance coverage
    Tags Employee benefits Weight management Labor economy
    From CNBC.com News
    Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
    Tags Eli Lilly and Co Biotech and Pharmaceuticals Health & Science
    From CNBC.com News
    Cramer's Lightning Round: Apple is a buy
    Tags Apple Inc Bristol/Myers Squibb Co Novo Nordisk A/S
    From CNBC.com News
    This new weight loss drug ETF bets big on two of the industry's leading players
    Tags U/S/ Markets Finance Zealand Pharma A/S
    From CNBC.com News
    How digital health companies are capitalizing on the GLP-1 boom
    Tags WW International Inc Technology Hims & Hers Health Inc
    From CNBC.com News
    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.